Forskning ved Københavns Universitet - Københavns Universitet

Forside

Diagnostic microbiology in veterinary dermatology: present and future

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Diagnostic microbiology in veterinary dermatology: present and future. / Guardabassi, Luca; Damborg, Peter; Stamm, Ivonne; Kopp, Peter A; Broens, Els M.; Toutain, Pierre-Louis.

I: Veterinary Dermatology, Bind 28, Nr. 1, 02.2017, s. 146–e30.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Guardabassi, L, Damborg, P, Stamm, I, Kopp, PA, Broens, EM & Toutain, P-L 2017, 'Diagnostic microbiology in veterinary dermatology: present and future', Veterinary Dermatology, bind 28, nr. 1, s. 146–e30. https://doi.org/10.1111/vde.12414

APA

Guardabassi, L., Damborg, P., Stamm, I., Kopp, P. A., Broens, E. M., & Toutain, P-L. (2017). Diagnostic microbiology in veterinary dermatology: present and future. Veterinary Dermatology, 28(1), 146–e30. https://doi.org/10.1111/vde.12414

Vancouver

Guardabassi L, Damborg P, Stamm I, Kopp PA, Broens EM, Toutain P-L. Diagnostic microbiology in veterinary dermatology: present and future. Veterinary Dermatology. 2017 feb;28(1):146–e30. https://doi.org/10.1111/vde.12414

Author

Guardabassi, Luca ; Damborg, Peter ; Stamm, Ivonne ; Kopp, Peter A ; Broens, Els M. ; Toutain, Pierre-Louis. / Diagnostic microbiology in veterinary dermatology: present and future. I: Veterinary Dermatology. 2017 ; Bind 28, Nr. 1. s. 146–e30.

Bibtex

@article{22b7e6698802402f88760283b4102a21,
title = "Diagnostic microbiology in veterinary dermatology: present and future",
abstract = "BackgroundThe microbiology laboratory can be perceived as a service provider rather than an integral part of the healthcare team.ObjectivesThe aim of this review is to discuss the current challenges of providing a state-of-the-art diagnostic veterinary microbiology service including the identification (ID) and antimicrobial susceptibility testing (AST) of key pathogens in veterinary dermatology.MethodsThe Study Group for Veterinary Microbiology (ESGVM) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) identified scientific, technological, educational and regulatory issues impacting the predictive value of AST and the quality of the service offered by microbiology laboratories.ResultsThe advent of mass spectrometry has significantly reduced the time required for ID of key pathogens such as Staphylococcus pseudintermedius. However, the turnaround time for validated AST methods has remained unchanged for many years. Beyond scientific and technological constraints, AST methods are not harmonized and clinical breakpoints for some antimicrobial drugs are either missing or inadequate. Small laboratories, including in-clinic laboratories, are usually not adequately equipped to run up-to-date clinical microbiologic diagnostic tests.Conclusions and clinical importanceESGVM recommends the use of laboratories employing mass spectrometry for ID and broth micro-dilution for AST, and offering assistance by expert microbiologists on pre- and post-analytical issues. Setting general standards for veterinary clinical microbiology, promoting antimicrobial stewardship, and the development of new, validated and rapid diagnostic methods, especially for AST, are among the missions of ESGVM.",
author = "Luca Guardabassi and Peter Damborg and Ivonne Stamm and Kopp, {Peter A} and Broens, {Els M.} and Pierre-Louis Toutain",
year = "2017",
month = "2",
doi = "10.1111/vde.12414",
language = "English",
volume = "28",
pages = "146–e30",
journal = "Veterinary Dermatology",
issn = "0959-4493",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - Diagnostic microbiology in veterinary dermatology: present and future

AU - Guardabassi, Luca

AU - Damborg, Peter

AU - Stamm, Ivonne

AU - Kopp, Peter A

AU - Broens, Els M.

AU - Toutain, Pierre-Louis

PY - 2017/2

Y1 - 2017/2

N2 - BackgroundThe microbiology laboratory can be perceived as a service provider rather than an integral part of the healthcare team.ObjectivesThe aim of this review is to discuss the current challenges of providing a state-of-the-art diagnostic veterinary microbiology service including the identification (ID) and antimicrobial susceptibility testing (AST) of key pathogens in veterinary dermatology.MethodsThe Study Group for Veterinary Microbiology (ESGVM) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) identified scientific, technological, educational and regulatory issues impacting the predictive value of AST and the quality of the service offered by microbiology laboratories.ResultsThe advent of mass spectrometry has significantly reduced the time required for ID of key pathogens such as Staphylococcus pseudintermedius. However, the turnaround time for validated AST methods has remained unchanged for many years. Beyond scientific and technological constraints, AST methods are not harmonized and clinical breakpoints for some antimicrobial drugs are either missing or inadequate. Small laboratories, including in-clinic laboratories, are usually not adequately equipped to run up-to-date clinical microbiologic diagnostic tests.Conclusions and clinical importanceESGVM recommends the use of laboratories employing mass spectrometry for ID and broth micro-dilution for AST, and offering assistance by expert microbiologists on pre- and post-analytical issues. Setting general standards for veterinary clinical microbiology, promoting antimicrobial stewardship, and the development of new, validated and rapid diagnostic methods, especially for AST, are among the missions of ESGVM.

AB - BackgroundThe microbiology laboratory can be perceived as a service provider rather than an integral part of the healthcare team.ObjectivesThe aim of this review is to discuss the current challenges of providing a state-of-the-art diagnostic veterinary microbiology service including the identification (ID) and antimicrobial susceptibility testing (AST) of key pathogens in veterinary dermatology.MethodsThe Study Group for Veterinary Microbiology (ESGVM) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) identified scientific, technological, educational and regulatory issues impacting the predictive value of AST and the quality of the service offered by microbiology laboratories.ResultsThe advent of mass spectrometry has significantly reduced the time required for ID of key pathogens such as Staphylococcus pseudintermedius. However, the turnaround time for validated AST methods has remained unchanged for many years. Beyond scientific and technological constraints, AST methods are not harmonized and clinical breakpoints for some antimicrobial drugs are either missing or inadequate. Small laboratories, including in-clinic laboratories, are usually not adequately equipped to run up-to-date clinical microbiologic diagnostic tests.Conclusions and clinical importanceESGVM recommends the use of laboratories employing mass spectrometry for ID and broth micro-dilution for AST, and offering assistance by expert microbiologists on pre- and post-analytical issues. Setting general standards for veterinary clinical microbiology, promoting antimicrobial stewardship, and the development of new, validated and rapid diagnostic methods, especially for AST, are among the missions of ESGVM.

U2 - 10.1111/vde.12414

DO - 10.1111/vde.12414

M3 - Review

C2 - 28133869

VL - 28

SP - 146–e30

JO - Veterinary Dermatology

JF - Veterinary Dermatology

SN - 0959-4493

IS - 1

ER -

ID: 176695282